A Nanoparticle-Encapsulated Non-Nucleoside Reverse-Transcriptase Inhibitor with Enhanced Anti-HIV-1 Activity and Prolonged Circulation Time in Plasma

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|7|925-935

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.7, 2015-02, pp. : 925-935

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Recent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Research Activity

By  

Current Medicinal Chemistry - Anti-Infective Agents, Vol. 1, Iss. 2, 2002-04 ,pp. : 119-140

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Non-Nucleoside Reverse Transcriptase Inhibitors for Anti-HIV Therapy

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 7, Iss. 2, 2008-04 ,pp. : 101-117

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and Anti-HIV Evaluation of Novel 1,2,4-triazole Derivatives as Potential Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 1, 2013-01 ,pp. : 27-34

Bentham Science Publishers

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M.   Morrison I.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite